NAMPT Antibody (Center) Blocking Peptide

Artikelnummer: ABT-BP9010C
Artikelname: NAMPT Antibody (Center) Blocking Peptide
Artikelnummer: ABT-BP9010C
Hersteller Artikelnummer: BP9010c
Alternativnummer: ABT-BP9010C-500UG
Hersteller: Abcepta
Kategorie: Proteine/Peptide
Alternative Synonym: Nicotinamide phosphoribosyltransferase, NAmPRTase, Nampt, Pre-B-cell colony-enhancing factor 1, Pre-B cell-enhancing factor, Visfatin, NAMPT, PBEF, PBEF1
NAMPT catalyzes the condensation of nicotinamide with 5-phosphoribosyl-1-pyrophosphate to yield nicotinamide mononucleotide, one step in the biosynthesis of nicotinamide adenine dinucleotide. The protein is an adipokine that is localized to the bloodstream and has various functions, including the promotion of vascular smooth muscle cell maturation and inhibition of neutrophil apoptosis. It also activates insulin receptor and has insulin-mimetic effects, lowering blood glucose and improving insulin sensitivity. The protein is highly expressed in visceral fat and serum levels of the protein correlate with obesity.
NCBI: 10135
UniProt: P43490
Formulierung: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Target-Kategorie: The synthetic peptide sequence used to generate the antibody AP9010c was selected from the Center region of human NAMPT. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.